Trojan Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.18 M
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.08 Cr
- Satisfied Charges ₹ 1.50 Cr
- Revenue Growth 109.96%
- Profit Growth 2274.66%
- Ebitda 0.52%
- Net Worth 46.20%
- Total Assets -14.66%
About Trojan Pharma
Trojan Pharma Limited (TPL) is a Public Limited Indian Non-Government Company incorporated in India on 25 October 2004 and has a history of 20 years and three months. Its registered office is in Jalandhar, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.18 M.
The company currently has active open charges totaling ₹3.08 Cr. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhuvan Bhaskar, Rashi Bhaskar, and Anil Bhaskar serve as directors at the Company.
Company Details
- Location
Jalandhar, Punjab, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24230PB2004PLC027593
- Company No.
027593
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Oct 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Trojan Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Bhaskar  | Managing Director | 25-Oct-2004 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhuvan Bhaskar | Director | 30-Mar-2010 | Current |
| Rashi Bhaskar | Director | 25-Oct-2004 | Current |
Financial Performance of Trojan Pharma.
Trojan Pharma Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 109.96% increase. The company also saw a substantial improvement in profitability, with a 2274.66% increase in profit. The company's net worth Soared by an impressive increase of 46.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trojan Pharma?
In 2021, Trojan Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Divinity Nutritions And Healthcare Private LimitedBhuvan Bhaskar and Anil Bhaskar are mutual person
- Divinity Healthcare Limited
Bhuvan Bhaskar and Anil Bhaskar are mutual person
- Bison Pharma Private Limited
Bhuvan Bhaskar and Anil Bhaskar are mutual person
- Divinity Wellness Private Limited
Bhuvan Bhaskar and Anil Bhaskar are mutual person
Charges (Loans)
₹30.81 M
₹15.00 M
Charges Breakdown by Lending Institutions
- Oriental Bank Of Commerce : 2.50 Cr
- District Industries Centre : 0.58 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Oct 2010 | District Industries Centre | ₹5.81 M | Open |
| 14 Jul 2006 | Oriental Bank Of Commerce | ₹2.50 Cr | Open |
| 26 Dec 2019 | Others | ₹1.50 Cr | Satisfied |
How Many Employees Work at Trojan Pharma?
Unlock and access historical data on people associated with Trojan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trojan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trojan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
